Research
Cellular
Statins are usually recommended as first-line treatment for dyslipidaemia.
Clinicians should consider statins as the first option for managing dyslipidaemia.
StrongSupportsmedium confidence
A statin is usually recommended first-line.
Why this rating
The claim is based on expert consensus.
Source
Klug E, Raal FJ, Marais AD, et al. South African Dyslipidaemia Guideline Consensus Statement 2018 Update: A joint statement from the South African Heart Association (SA Heart) and the Lipid and Atherosclerosis Society of Southern Africa (LASSA). S Afr Med J 2018;108(11b):973-1000
EQ Klug et al. · South African Medical Journal · 2018
DOI 10.7196/samj.2018.v108i11.13383
otherCited 50×
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- Cholesterol reduction combined with aggressive management of modifiable risk factors can help reduce and prevent morbidity and mortality in individuals at increased risk of cardiovascular events.Strong
- Therapeutic lifestyle change is the mainstay of management for all patients with dyslipidaemia.Strong
Related findings · Cellular
- Athletes aiming to reduce fat mass and preserve FFM should consume protein intakes in the range of ∼1.8-2.7 g kg(-1) d(-1).Strong
- A minimum daily protein intake of ≥1.6 g/kg is necessary to observe significant improvements in muscle mass from whey protein supplementation.Strong
- Most athletes ideally need 1.2 to 2.0 grams/kg of body weight/day of protein, preferably split across 3-4 meals.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →